Updates matching "Access to Biomarker Testing"

CHARLESTON, W. Va. –Delegate Steve Westfall recently introduced legislation that would increase access to biomarker testing, which can help determine the best treatment plan for a specific patient. Despite its benefits, access to biomarker testing has not kept pace with the rate of innovation due to several barriers, including lack

TRENTON, NJ – JANUARY 12, 2024 – As lawmakers dive into the 2024 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on New Jerseyans, securing each resident equal opportunity to prevent, detect, treat and survive

DES MOINES, Iowa - Statement from Jackie Cale, American Cancer Society Cancer Action Network (ACS CAN) Iowa government relations director: “As lawmakers dive into the 2024 legislative session, ACS CAN urges legislators to prioritize passing legislation to ease the burden of cancer on Iowans. According to the 2023 Cancer

As lawmakers dive into the 2024 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on Hoosiers.

As lawmakers dive into the 2024 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on Buckeyes.

As Washington legislators convene for the new session, it is crucial for them to prioritize cancer patients and cancer care by assuring all residents have ready access to biomarker testing.

ALBANY, NY – DECEMBER 22, 2023 – Today, Governor Kathy Hochul signed Senate Bill 1196a / Assembly Bill 1673a into law, securing a major win for patients across New York. The new law will require all state-regulated health plans, including Medicaid, to cover comprehensive biomarker testing, which will enable

ANNAPOLIS, MD – DECEMBER 20, 2023 – On January 1, 2024, Marylanders will gain access to biomarker testing when Chapter 322 of the Laws of 2023 takes effect for private insurers. The legislation, which requires coverage of biomarker testing when supported by scientific and medical evidence, received near-unanimous support

TALLAHASSEE, Fla. – Rep. Karen Gonzalez Pittman (R-Tampa) and Sen. Alexis Calatayud (R- Miami) filed bills today ( HB 885 and SB 964 ) that will allow more Floridians to access biomarker testing , which has become an increasingly important part of cancer care in